Will therapeutic peptides be kryptonite for superantigens?
- 1 April 2000
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 6 (4) , 378-379
- https://doi.org/10.1038/74630
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activationNature Medicine, 2000
- Three-Dimensional Structure of the Complex between a T Cell Receptor β Chain and the Superantigen Staphylococcal Enterotoxin BImmunity, 1998
- Severe invasive group A streptococcal disease: Clinical description and mechanisms of pathogenesisJournal of Laboratory and Clinical Medicine, 1996
- Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigenNature, 1994
- The Staphylococcal Enterotoxins and Their RelativesScience, 1990
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.The Journal of Immunology, 1988
- A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1Infection and Immunity, 1987
- TOXIC-SHOCK SYNDROME ASSOCIATED WITH PHAGE-GROUP-I STAPHYLOCOCCIThe Lancet, 1978